image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Innovaderma - Gain in two months: 64%

August 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • IDP
  • Price:
  • 395p
The shares surged to a new high of 423p after Innovaderma said results to end of June ’16 would be well ahead of expectations with year on year growth of 80% to c. £9m (previous forecast £7m) bolstered by the exceptional performance of Skinny Tan. Underlying pretax profit is expected to be around £1.28m versus a previous forecast of £0.77m.It’s also announced a deal with Superdrug to supply five products in its hair care range to its top 400 stores in the UK from August this year. Alongside this it will stock its new skincare product, BodyGlow, to 500 Superdrug stores.Broker Hybridian has introduced a new forecast for the year starting 1st July ’17 for sales of £14.1m, pretax pr ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X